Opportunities and Challenges in the Anticandidal Drug Discovery and Development

Mohammad Abid

doi:10.2174/157018081605190415121529

ISSN: 1570-1808
E-ISSN: 1875-628X

oa Opportunities and Challenges in the Anticandidal Drug Discovery and Development
By Mohammad Abid
Source: Letters in Drug Design & Discovery, Volume 16, Issue 5, May 2019, p. 477 - 477
DOI: https://doi.org/10.2174/157018081605190415121529
- Available online: 01 May 2019

Previous Article
Table of Contents
Next Article

There is no abstract available.

Article metrics loading...

/content/journals/lddd/10.2174/157018081605190415121529

2019-05-01

2025-07-07

From This Site

/content/journals/lddd/10.2174/157018081605190415121529

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

/content/journals/lddd/10.2174/157018081605190415121529

Article Type: Editorial

Most Cited Most Cited RSS feed

- Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides
  
  Authors: Yulin Ren, Yawei Zhou, Xiaozhuo Chen and Yunhua Ye
- Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance
  
  Authors: Joseph Molnar, Barry S. Thornton, Annamaria Molnar, Dezso Gaal, Liaofu Luo and Elke S. Bergmann-Leitner
- Immunomodulatory Properties of Synthetic Imidazolone Derivatives
  
  Authors: M. A. Mesaik, K. M. Khan, S. Rahat, Zia-Ullah, M. I. Choudhary, S. Murad, N. R. Abdullah, Atta-ur-Rahman, A. Ahmad and R. A. Siddiqui
- Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies
  
  Authors: Ossama Daoui, Souad Elkhattabi and Samir Chtita
- Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
  
  Authors: Kazuhiro Honda, Paula I. Moreira, Quan Liu, Sandra L. Siedlak, Xiongwei Zhu, Mark A Smith and George Perry
- Identifying Protein Binding Sites and Optimal Ligands
  
  Authors: Albert Beuscher, Arthur J. Olson and David S. Goodsell
- Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas
  
  Authors: B. Crescenzi, M. Poma, J. M. Ontoria, A. Marchetti, E. Nizi, V. G. Matassa and C. Gardelli
- Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides
  
  Authors: S. Ponzi, C. Giuliano, M. Donghi, M. Poma, V. G. Matassa and I. Stansfield
- Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product
  
  Authors: T. Taki, S. Fujita and K. Taira
- A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development
  
  Authors: Mridula Chauhan, Shivansh Kumar, Arpon Biswas, Mukesh Kumar, Sarvesh Kumar Verma, Anjali Mishra, Vaishali Singh, Amol Chhatrapati Bisen, Sristi Agrawal, Abhijit Deb Choudhury, Ramakrishna Rayiti and Rabi Sankar Bhatta
More Less

oa Opportunities and Challenges in the Anticandidal Drug Discovery and Development

Most Read This Month

Most Cited Most Cited RSS feed